Related Experiment Videos

Strategies for cancer gene therapy

¹Dana Farber Cancer Inst., Boston, MA, USA.

Cancer Chemotherapy and Biological Response Modifiers

|January 1, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients.

Leukemia·2014

Targeting melanoma inhibitor of apoptosis protein with cancer immunotherapy.

Apoptosis : an international journal on programmed cell death·2004

CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.

Proceedings of the National Academy of Sciences of the United States of America·2001

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.

Blood·2001

Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3.

Blood·2001

Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation.

Cancer research·2001

See all related articles